The market for migraine preventatives has evolved greatly in the past year. To improve patient outcomes and support stakeholders, pharmaceutical companies active in this fast-changing category will need to navigate a host of clinical, financial, societal and emotional factors influencing migraine patients, providers, and payers.

Find out which factors brands need to understand to get closer to migraine customers and identify which activities have the greatest potential to impact outcomes.

These dynamics, as well as complex patient, provider, and payer relationships and influences, make migraine commercial planning challenging.

DRG experts can help you prioritize the right questions and data sources to get you closer to your migraine customers.

To know COVID-19 is to know medicine

View Now